Trial intelligence / Profile preview

Lisinopril for Renal Protection in Postpartum Preeclamptic Women

NCT05016440Withdrawn

Sponsor
Eastern Virginia Medical School
Start
Sep 2015
Primary completion
Sep 2015
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of lisinopril in Microalbuminuria and hypertension (HTN) (2 arms), sponsored by Eastern Virginia Medical School. Primary endpoint: Albumin Excretion Rate. Planned start Sep 2015; status: withdrawn.

02

Drugs

lisinopril
03

Conditions

Microalbuminuriahypertension (HTN)

Beyond the preview

Go deeper on NCT05016440.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05016440.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call